LMR Partners’s 89bio ETNB Stock Holding History

LMR Partners’s Portfolio ETNB Stock Details ETNB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-1,800,000	Closed	-$26.5M	–	1585
2025 Q3	$26.5M	Buy	+1,800,000	New	+$18.3M	0.12%	141
2025 Q2	–	Sell	-50,000	Closed	-$364K	–	1462
2025 Q1	$364K	Buy	+50,000	New	+$437K	﹤0.01%	976
2023 Q4	–	Sell	-32,900	Closed	-$508K	–	1033
2023 Q3	$508K	Buy	+32,900	New	+$552K	0.01%	557

Other funds holding ETNB

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

LMR Partners's ETNB Position: Q4 2025 in Review

LMR Partners sold out of 89bio (ETNB) in Q4 2025, closing a stake of 1,000,000 shares — an estimated $14.7M sold.

LMR Partners first reported a position in ETNB in Q4 2022 and held it in 4 quarters. The position peaked at $14.7M in Q3 2025. 2 funds tracked by Wall St. Rank hold ETNB as of Q4 2025.

LMR Partners reported no remaining 89bio position as of Q4 2025 after selling out during the quarter.
LMR Partners sold 1,000,000 89bio shares in Q4 2025, an estimated $14.7M.
LMR Partners first reported a position in 89bio in Q4 2022 and held it in 4 quarters.
LMR Partners's 89bio position peaked at $14.7M in Q3 2025.
2 funds tracked by Wall St. Rank held 89bio as of Q4 2025.

Based on LMR Partners's 13F filing for Q4 2025, filed 17 Feb 2026.